| Ytd | -1.83% | |
| 1y | -40.37% |
| Open | 1.59 | Prev Close | 1.56 | Low | 1.57 | High | 1.62 | Mkt Cap | 7.06M |
| Vol | 11.70K | Avg Vol | 364.41K | EPS | -2.89 | P/E | -0.54 | Forward P/E | N/A |
| Beta | 2.43 | Short Ratio | 0.89 | Inst. Own | 1.34% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-08 | 50-d Avg | 1.92 | 200-d Avg | 2.09 | 1yr Est | 0.00 |
AIMD News
AI Nose deployments have generated approximately 613 million industrial scent data points since Dece
Gainers The Growhub (NASDAQ:TGHL) shares rose 60.9% to $1.31 during Thursday's pre-market sessi
Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a Smell AI compa
HOUSTON, TX / ACCESS Newswire / June 22, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or
Program expands Ainos' Smell AI platform from environmental intelligence into digital breath intelli
Building the Olfactory Layer of Physical AI Highlighting Progress Across Semiconductor Manufacturing
HOUSTON, TX / ACCESS Newswire / June 5, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or t
HOUSTON, TX / ACCESS Newswire / June 3, 2026 / Ainos, Inc. (NASDAQ:AIMD, AIMDW) ("Ainos" or the "Com
AI Nose Expands from Semiconductor Facilities into Frontline Healthcare Infrastructure HOUSTON, TX /
Semtech Corp (SMTC) reported strong Q1 financial results, beating analysts' estimates. Shares ro
HOUSTON, TX / ACCESS Newswire / May 20, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or t
HOUSTON, TX / ACCESS Newswire / May 13, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or t
Updated classification reflects Ainos' transition toward AI-powered scent intelligence commercializa
2026 Identified as a Key Scale-Up Phase with Expanding Market Verticals and Accelerating Data Flywhe
Ainos, Inc. (NASDAQ: AIMD - Get Free Report) was the recipient of a large decline in short interest
Expands AI Nose platform from industrial safety into clinical infrastructure HOUSTON, TX / ACCESS Ne
Report highlights transition to deployment-driven growth, with visible semiconductor rollout and ear
AI Nose drove 499% revenue growth in 2025, with gross margin turning positive to 82.9% 2025 partners
As AI expands beyond vision and language, Ainos advances commercial deployment of AI Nose in industr
Ainos, Inc. (NASDAQ: AIMD - Get Free Report) was the target of a large decline in short interest in
AI Nose deployment into front-end wafer fabrication facilities marks a critical validation step in s
Company affirms execution milestones, subscription activation roadmap, and long-term infrastructure
Xenetic Biosciences (NASDAQ: XBIO - Get Free Report) and Ainos (NASDAQ: AIMD - Get Free Report) are
Shares of SOPHiA GENETICS SA (NASDAQ: SOPH) fell sharply during Tuesday’s session after the company
Gainers Panbela Therapeutics, Inc. (NASDAQ: PBLA) shares jumped 53% to close at $0.58 on Friday.